Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

3 clinical studies listed.

Filters:

Immune Checkpoint Inhibitor-Related Myocarditis

Tundra lists 3 Immune Checkpoint Inhibitor-Related Myocarditis clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

RECRUITING

NCT07644715

AI-powered ECG Analysis for Deadly Arrhythmias and ICI Myocarditis

ELDORA is a non-interventional observational data-science study aiming to develop and validate clinical-grade artificial intelligence tools applied to electrocardiogram (ECG) data. The project will standardize heterogeneous ECGs, create the ECGInsight harmonized database, and train interpretable models for life-threatening arrhythmia risk prediction, especially Torsades-de-Pointes/long QT syndrome and immune checkpoint inhibitor (ICI)-induced myocarditis. The project uses existing and ongoing national and international ECG cohorts with de-identified clinical metadata; AI outputs are intended for research/model development and are not used to drive patient care during the study.

Gender: All

Updated: 2026-06-12

Arrhythmia
Long QT Syndrome
Immune Checkpoint Inhibitor-Related Myocarditis
RECRUITING

NCT05598879

Global Cardio Oncology Registry

G-COR is the first Global Prospective Cardio-Oncology Registry. It is a multinational, multicenter prospective observational cohort registry, with the goal of collecting clinical, laboratory, imaging, demographic, and socioeconomic data to identify risk factors associated with increased incidence of cancer therapy related cardiovascular toxicity (CTR-CVT) in different settings and to derive and validate risk scores for cardio oncology patients treated in different geographic locations throughout the world.

Gender: All

Ages: 18 Years - Any

Updated: 2026-05-12

1 state

Breast Cancer
Hematologic Malignancy
Immune Checkpoint Inhibitor-Related Myocarditis
+2
NOT YET RECRUITING

NCT07278817

Monitoring and Rehabilitation for ICIACI Rehabilitation:A Cohort Study

Immune checkpoint inhibitor-associated cardiac injury (ICIACI) is a low-incidence but highly fatal adverse event. A significant knowledge gap exists regarding the disease characteristics and recovery status of patients during the ICIACI convalescent phase. The objectives of this study are to establish a national, multicenter cohort for this patient population and to comprehensively describe their clinical profiles from an integrated Traditional Chinese and Western medicine standpoint, as well as their current rehabilitation status.

Gender: All

Ages: 18 Years - 80 Years

Updated: 2025-12-12

Immune Checkpoint Inhibitor-Related Myocarditis